IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Oct 2004 (Vol: 2004, Issue: 52)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
Royalty Rates - What is There to Hide? Published: 1 Oct-2004
By: Fintan Walton
Abstract Fulltext:
Section: Company Profile
NicOx SA Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:
Section: Deal Trackers
Ampligen (polyI:polyC12U) Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
New Distributor for Cedax® in the US Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:
Section: General
MGI Pharma’s US$122 M Oncology Spree Published: 4 Oct-2004
By: Business Review Editor
Abstract
Section: Licensing
Transition Licenses Diabetes Regenerative Therapy to Novo Nordisk Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:
Pfizer Licenses Nitric Oxide-Donating Compounds from NicOx Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Mylan to Acquire King for US$4 B Published: 4 Oct-2004
By: Business Review Editor
Abstract
Pfizer Sells Two of its Generics Units Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Biogen Idec and Sunesis Sign Small Molecule Cancer Agreement Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in